New antibiotic promising for complicated UTIs Vinay Singh singh27 Oct 2018 8:28 PM ISTResults from a phase 2 randomized trial suggest that a new investigational antibiotic, cefiderocol, is as effective as the current standard-of-care...
New topical lotion for Plaque Psoriasis coming soon Vinay Singh singh10 Nov 2018 7:28 PM ISTThe U.S. Food and Drug Administration (FDA) approved BYHALIA Lotion indicated for the topical treatment of plaque psoriasis in adult patients,...
FDA approves once-daily, inhalation solution for COPD Vinay Singh singh13 Nov 2018 7:28 PM ISTThe U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for YUPELRI (revefenacin) inhalation solution for the...
Once a month injectable available for schizophrenia Dr. Kamal Kant Kohli Kohli20 Nov 2018 7:28 PM ISTRisperidone long-acting once-month subcutaneous (SC) injectable, is now available for the treatment of schizophrenia. FDA had approved long-acting...
FDA clears VNS Therapy for prevention of Cluster Headache Vinay Singh singh30 Nov 2018 7:25 PM ISTThe U.S Food and Drug Administration (FDA) issued clearance certification to gammaCore, a non-invasive vagus nerve stimulator (nVNS) therapy, for...
Xyosted launched for Treatment of Testosterone Deficiency Hina Zahid1 Dec 2018 7:28 PM ISTXyosted (testosterone enanthate) Injection indicated for testosterone replacement therapy in adult males has been launched by Antares Pharma for...
New light based Illuvinate System now available for Plaque Psoriasis Vinay Singh singh9 Dec 2018 7:10 PM ISTThe U.S FDA has approved, illuvinate system, a light-based therapy to treat plaque psoriasis, announced Luma Therapeutics. The system is intended for...
FDA Approves drug for Thrombocytopenia in children Hina Zahid15 Dec 2018 7:28 PM ISTU.S. Food and Drug Administration (FDA) has approved romiplostim for treatment of pediatric patients one year of age and older with immune...
FDA approves Prucalopride, for adult chronic constipation Medha Baranwal Baranwal18 Dec 2018 7:25 PM ISTThe U.S. Food and Drug Administration (FDA) has approved Shire's Motegrity (prucalopride) tablets for the treatment of chronic idiopathic constipation...
FDA approves Asparlas for acute lymphoblastic leukemia Hina Zahid22 Dec 2018 7:05 PM ISTThe FDA has approved calaspargase pegol-mknl for acute lymphoblastic leukaemia as part of a multiagent chemotherapeutic regimen for pediatric and...
Fluoroquinolones can cause serious heart damage, FDA warns Vinay Singh singh23 Dec 2018 7:04 PM ISTThe US. Food and Drug Administration (FDA) issued a warning that fluoroquinolone antibiotics can increase the occurrence of rare but serious events of...
FDA clears Freespira- A digital solution for Post-traumatic stress disorder Vinay Singh singh23 Dec 2018 7:25 PM ISTThe U.S FDA has granted clearance to Freespira, a new digital therapeutic for the treatment of post-traumatic stress disorder (PTSD), announced Palo...
